These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1079 related articles for article (PubMed ID: 23911820)
1. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Sun L; Feng J; Ma L; Liu W; Zhou Z Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820 [TBL] [Abstract][Full Text] [Related]
2. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma. Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414 [TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus. Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659 [TBL] [Abstract][Full Text] [Related]
4. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. Ogmundsdóttir HM; Björnsson J; Holbrook WP J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450 [TBL] [Abstract][Full Text] [Related]
5. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression. Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895 [TBL] [Abstract][Full Text] [Related]
7. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study. Sudha VM; Hemavathy S Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045 [TBL] [Abstract][Full Text] [Related]
8. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma]. Cao J; Jin JQ; Deng DJ; Liu HW Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914 [TBL] [Abstract][Full Text] [Related]
9. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus. Shi P; Liu W; Zhou ZT; He QB; Jiang WW Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437 [TBL] [Abstract][Full Text] [Related]
10. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703 [TBL] [Abstract][Full Text] [Related]
11. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia. Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852 [TBL] [Abstract][Full Text] [Related]
12. Suitability/unsuitability of cell proliferation as an indicator of malignant potential in oral lichen planus: an immunohistochemical study. Zargaran M; Jamshidi S; Eshghyar N; Moghimbeigi A Asian Pac J Cancer Prev; 2013; 14(11):6979-83. PubMed ID: 24377636 [TBL] [Abstract][Full Text] [Related]
13. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential. Lončar-Brzak B; Klobučar M; Veliki-Dalić I; Sabol I; Kraljević Pavelić S; Krušlin B; Mravak-Stipetić M Clin Oral Investig; 2018 Mar; 22(2):1071-1082. PubMed ID: 28779221 [TBL] [Abstract][Full Text] [Related]
14. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study. Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035 [TBL] [Abstract][Full Text] [Related]
15. [The role of matrix metalloproteinases and their tissue inhibitors in oral lichen planus]. Zhang WP; Chen Y; Geng N; Tian K; Bao DM; Yang MZ Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul; 41(7):420-1. PubMed ID: 17067460 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of survivin expression in leukoplakia, lichen planus, and oral squamous cell carcinoma: An immunohistochemical study. Angelin D; Nair BJ J Cancer Res Ther; 2020; 16(3):569-574. PubMed ID: 32719269 [TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma. Jaafari-Ashkavandi Z; Aslani E Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma. Segura S; Rozas-Muñoz E; Toll A; Martín-Ezquerra G; Masferrer E; Espinet B; Rodriguez M; Baró T; Barranco C; Pujol RM Br J Dermatol; 2013 Jul; 169(1):106-14. PubMed ID: 23461699 [TBL] [Abstract][Full Text] [Related]
19. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP. Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830 [TBL] [Abstract][Full Text] [Related]
20. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]